Got the results for the MSG supplementation clinical trials.Here is the complete procedure we followed:
1. On January 5 ,2012 we gathered a new set of volunteers, specifically, people who consumed piracetam were selected. (we had to sort out about 53,000 survey forms and also verify them). Thankfully, we got help from a couple of universities who were also interested in this particular research.
2. Over the following week we gathered 150 individuals and tested each individual for sensitivity to MSG (Mono-Sodium Glutamate) by having them consume 100mg of MSG and then monitoring their blood pressure,sugar levels and verifying it with the CSF. We also tested other factors that were required for their first clinical trial, such as, cardiovascular problems, diseases, smoking history, etc.
3. On January 13,2012 we got the results for the individuals who were sensitive to MSG. The results showed that out of 150 people, 27 of them were sensitive to MSG and hence were eliminated. We then determined the maximum MSG tolerance of each individual on the same day, (incremental dosage of MSG was given). Based on this, the people were divided in to 3 categories.
4. On January 14,2012; the clinical trials began.
5. The trials ended on January 21,2012; a week after it had started.
Here is how the Clinical Trials proceeded:Total no. of people: 123
- The first set of people consisted of 21 people. These people were given 500mg of MSG. The volunteers in the first set had high tolerance rates (above 1 gram).
- The second set of people consisted of 74 people. These people were given exactly 100mg of MSG. The volunteers in the second set had average tolerance rates (100mg - 500mg)
- The third set of people consisted of 28 people. These people were given 25mg of MSG. The volunteers in this group had slightly low tolerance rates (100mg - 250mg)
The clinical trials were performed in double blind placebo controlled study and volunteers were secretly given piracetam and 500mg choline along with MSG. They knew that they were going to be given MSG but did not know about the other 2 substances.Here are the Results:- In the first set; 12 of the volunteers exhibited enhanced cognitive abilities without any side effects based on their experience reports, mental/physiology test results and blood tests. While the other 9 people exhibited signs of restlessness with slightly improved cognitive abilities.
- In the second set; 55 of the volunteers exhibited signs of improved,memory,speech and cognitive abilities based on their experience report, mental/physiology test results and blood tests. While the other 19 people exhibited no improvement.
- In the third set; all 28 people exhibited slightly improved speech based on their experience report, mental/physiology test results and blood tests.
From the above trials, we tried to rule out the fluctuations of responders and non-responders which again led us to the correlation between their calcium and choline intake. (This was tested through MRI density scans,blood tests and CSF).The above results were carried out over the course of one week and based on the results, we have concluded that MSG is a viable supplementation for glutamate intake, but, not a completely suitable one because it does not allow all the functions of piracetam to express its true potential. It also not suitable because it also has a potential health hazard.Recommendation:The recommendation made is not by our team but by a panel of professors, highly qualified neurologists and health specialists.
- MSG should be avoided as a glutamate supplement and should only be consumed at around 100mg (±25mg) in case of absolute emergencies or during low body glucose levels.
- MSG should not be consumed everyday. It may lead to a few neurological disorders.
We thank our our professors and the various people who helped us in this research. We also thank the universities who have joined us in our research and are willing to fund it. (The names of these universities cannot be mentioned due to legal issues)
We made sure that none of the volunteers were harmed in any way during the clinical trial.
This report has been retyped in a way so that, average, non-scientific readers and the general public can apprehend it.
END OF REPORT
Edited by Hyperspace21, 22 February 2012 - 12:56 PM.